ATE478941T1 - Vorläuferzellen aus der wharton sulze von humanen nabelschnüren - Google Patents

Vorläuferzellen aus der wharton sulze von humanen nabelschnüren

Info

Publication number
ATE478941T1
ATE478941T1 AT04709560T AT04709560T ATE478941T1 AT E478941 T1 ATE478941 T1 AT E478941T1 AT 04709560 T AT04709560 T AT 04709560T AT 04709560 T AT04709560 T AT 04709560T AT E478941 T1 ATE478941 T1 AT E478941T1
Authority
AT
Austria
Prior art keywords
wharton
julk
human umbilical
cells
umbilical cords
Prior art date
Application number
AT04709560T
Other languages
English (en)
Inventor
John E Davies
Dolores Baksh
Rahul Sarugaser
Morris Hosseini
Antony David Sutton Lickorish
Original Assignee
John E Davies
Dolores Baksh
Rahul Sarugaser
Morris Hosseini
Antony David Sutton Lickorish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John E Davies, Dolores Baksh, Rahul Sarugaser, Morris Hosseini, Antony David Sutton Lickorish filed Critical John E Davies
Application granted granted Critical
Publication of ATE478941T1 publication Critical patent/ATE478941T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT04709560T 2003-02-11 2004-02-10 Vorläuferzellen aus der wharton sulze von humanen nabelschnüren ATE478941T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44627503P 2003-02-11 2003-02-11
PCT/CA2004/000182 WO2004072273A1 (en) 2003-02-11 2004-02-10 Progenitor cells from wharton's jelly of human umbilical cord

Publications (1)

Publication Number Publication Date
ATE478941T1 true ATE478941T1 (de) 2010-09-15

Family

ID=32869477

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04709560T ATE478941T1 (de) 2003-02-11 2004-02-10 Vorläuferzellen aus der wharton sulze von humanen nabelschnüren

Country Status (13)

Country Link
US (5) US7547546B2 (de)
EP (2) EP2277992A3 (de)
JP (1) JP4790592B2 (de)
KR (1) KR101077760B1 (de)
AT (1) ATE478941T1 (de)
AU (2) AU2004210891B2 (de)
BR (1) BRPI0407221A (de)
CA (1) CA2515469C (de)
DE (1) DE602004028803D1 (de)
ES (1) ES2351386T3 (de)
IL (2) IL170221A (de)
PT (1) PT1594957E (de)
WO (1) WO2004072273A1 (de)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3299452A1 (de) 2000-12-06 2018-03-28 Anthrogenesis Corporation Verfahren zum sammeln plazentärer stammzellen
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
CA3046566A1 (en) * 2001-02-14 2002-08-22 Anthrogenesis Corporation Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
IL157392A0 (en) 2001-02-14 2004-02-19 Robert J Hariri Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
CA2515469C (en) 2003-02-11 2013-12-17 John E. Davies Progenitor cells from wharton's jelly of human umbilical cord
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US7875272B2 (en) * 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
CA2530732C (en) 2003-06-27 2015-03-31 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US8518390B2 (en) 2003-06-27 2013-08-27 Advanced Technologies And Regenerative Medicine, Llc Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US8491883B2 (en) 2003-06-27 2013-07-23 Advanced Technologies And Regenerative Medicine, Llc Treatment of amyotrophic lateral sclerosis using umbilical derived cells
AU2004280616A1 (en) 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
AU2005273077B2 (en) * 2004-08-16 2011-02-24 Cellresearch Corporation Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.
US20060153815A1 (en) * 2004-12-21 2006-07-13 Agnieszka Seyda Tissue engineering devices for the repair and regeneration of tissue
WO2006083394A2 (en) * 2004-12-21 2006-08-10 Ethicon, Inc. Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
US20060171930A1 (en) * 2004-12-21 2006-08-03 Agnieszka Seyda Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
WO2006071802A2 (en) 2004-12-23 2006-07-06 Ethicon Incorporated Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
EP1831355A2 (de) * 2004-12-23 2007-09-12 Ethicon, Inc. Weichgewebe reparatur und regenerierung mit postpartum abgeleiteten zellen
WO2006071773A2 (en) * 2004-12-23 2006-07-06 Ethicon Incoporated Treatment of osteochondral diseases using postpartum-derived cells and products thereof
CA2589041C (en) * 2004-12-23 2019-08-20 DePuy Synthes Products, Inc. Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
EP1957633B1 (de) 2005-10-13 2013-12-18 Anthrogenesis Corporation Immunmodulation unter verwendung von plazentastammzellen
CA2629283A1 (en) * 2005-11-14 2007-05-24 The New England Medical Center Hospitals, Inc. Methods for preparing cord matrix stem cells (cmsc) for long term storage and for preparing a segment of umbilical cord for cryopreservation
JP5289970B2 (ja) 2005-12-16 2013-09-11 エシコン・インコーポレイテッド 組織適合性不適合な移植における逆免疫反応を抑制するための組成物および方法
AU2006327073B2 (en) * 2005-12-19 2012-08-30 Ethicon, Inc. In vitro expansion of postpartum derived cells in roller bottles
CA2634820C (en) * 2005-12-22 2021-05-25 Jane Ennis Viable cells from frozen umbilical cord tissue
CN101437576A (zh) * 2005-12-28 2009-05-20 伊西康公司 使用产后衍生细胞治疗外周血管疾病
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
ES2711278T3 (es) 2005-12-29 2019-04-30 Celularity Inc Poblaciones de células madre placentarias
CN101389754A (zh) 2005-12-29 2009-03-18 人类起源公司 胎盘干细胞和第二来源干细胞的联合培养
US20090280093A1 (en) * 2006-03-01 2009-11-12 The Regenerative Medicine Institute Compositions and populations of cells obtained from the umbilical cord and methods of producing the same
JP5431146B2 (ja) 2006-05-05 2014-03-05 デイビーズ，ジヨン・イー 免疫学的寛容および調節性前駆細胞
US20080050814A1 (en) * 2006-06-05 2008-02-28 Cryo-Cell International, Inc. Procurement, isolation and cryopreservation of fetal placental cells
WO2007146106A2 (en) * 2006-06-05 2007-12-21 Cryo- Cell International, Inc. Procurement, isolation and cryopreservation of maternal placental cells
EP2035552A2 (de) * 2006-06-09 2009-03-18 Anthrogenesis Corporation Plazentare nische und ihre verwendung zur züchtung von stammzellen
US7993918B2 (en) * 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
KR100902569B1 (ko) * 2007-01-19 2009-06-11 재단법인서울대학교산학협력재단 인간 탯줄 유래 중간엽 줄기세포 및 이의 확립방법
WO2008060037A1 (en) * 2006-11-15 2008-05-22 Seoul National University Industry Foundation Method for the simultaneous primary-isolation and expansion of endothelial stem/progenitor cell and mesenchymal stem cell derived from mammal including human umbilical cord
WO2008073331A2 (en) * 2006-12-07 2008-06-19 Teva Pharmaceutical Industries Ltd. Method of generation and expansion of tissue-progenitor cells and mature tissue cells from intact bone marrow or intact umbilical cord tissue
NZ597779A (en) 2007-02-12 2013-07-26 Anthrogenesis Corp Treatment of inflammatory diseases using placental stem cells
WO2009021333A1 (en) * 2007-08-14 2009-02-19 Tissue Regeneration Therapeutics Inc. Blood vessel extraction from umbilical cord
CA2630708C (en) * 2007-09-13 2017-08-01 Clifford L. Librach Method of isolation and use of cells derived from first trimester umbilical cord tissue
US12129481B2 (en) 2007-09-13 2024-10-29 Reprobiogen Inc. Use of cells derived from first trimester umbilical cord tissue
US10925903B2 (en) 2007-09-13 2021-02-23 Reprobiogen Inc. Use of cells derived from first trimester umbilical cord tissue
PT2203176E (pt) 2007-09-28 2015-03-02 Anthrogenesis Corp Supressão de tumor utilizando perfusato placentário humano e células assassinas naturais intermédias derivadas de placenta humanas
UA99152C2 (ru) * 2007-10-05 2012-07-25 Этикон, Инкорпорейтед Восстановление и регенерация почечной ткани с использованием клеток, полученных с человеческой ткани пупочного канатика
RU2461622C2 (ru) * 2007-11-28 2012-09-20 Огенодженесис, Инк. Биоинженерный конструкт для имплантации ткани и способ изготовления названного биоинженерного конструкта (варианты)
US8236538B2 (en) * 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
WO2009129616A1 (en) 2008-04-21 2009-10-29 Tissue Regeneration Therapeutics, Inc. Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
AU2009283216B2 (en) 2008-08-20 2015-04-02 Celularity Inc. Improved cell composition and methods of making the same
PE20110399A1 (es) 2008-08-20 2011-06-22 Anthrogenesis Corp Tratamiento de la apoplejia utilizando celulas placentarias aisladas
KR20110050688A (ko) 2008-08-22 2011-05-16 안트로제네시스 코포레이션 태반 세포 집단을 이용한 골 결함의 치료 방법 및 골 결함 치료 조성물
MX2011005229A (es) 2008-11-19 2011-06-16 Anthrogenesis Corp Celulas adherentes derivadas del amnios.
BRPI0923068B1 (pt) 2008-12-19 2021-05-25 Advanced Technologies And Regenerative Medicine, Llc Uso de células derivadas de tecido de cordão umbilical para tratar um paciente tendo uma doença, distúrbio ou injúria pulmonar
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
US8771677B2 (en) 2008-12-29 2014-07-08 Vladimir B Serikov Colony-forming unit cell of human chorion and method to obtain and use thereof
ES2629003T3 (es) * 2009-03-26 2017-08-07 DePuy Synthes Products, Inc. Células de tejido de cordón umbilical humano como tratamiento para la enfermedad de alzheimer
CA2784787A1 (en) * 2009-12-18 2011-06-23 Lifeline Cord Blood Bank Methods for isolating mononuclear cells that include a subpopulation of mesenchymal progenitor cells and vascular cells that include a subpopulation of endothelial progenitor cells from umbilical cord tissue
AU2011205674A1 (en) * 2010-01-14 2012-08-09 Organogenesis, Inc. Bioengineered tissue constructs and methods for producing and using thereof
MX2012008636A (es) 2010-01-26 2012-10-15 Anthrogenesis Corp Tratamiento de canceres relacionados con el hueso utilizando celulas madre placenterias.
EP2552457B1 (de) 2010-03-30 2015-07-29 Histocell, S.L. Biomaterial aus der wharton-sulze einer nabelschnur
US9254302B2 (en) 2010-04-07 2016-02-09 Anthrogenesis Corporation Angiogenesis using placental stem cells
EP2555783A1 (de) 2010-04-08 2013-02-13 Anthrogenesis Corporation Behandlung von sarkoidose mithilfe von stammzellen aus der plazenta
CA2801009C (en) 2010-06-01 2021-10-26 Auxocell Laboratories, Inc. Native wharton's jelly stem cells and their purification
KR20220053695A (ko) 2010-07-13 2022-04-29 셀룰래리티 인코포레이티드 천연 킬러 세포의 생성 방법
CA2838330C (en) 2010-08-23 2021-01-26 President And Fellows Of Harvard College Optogenetic probes for measuring membrane potential
AU2011352036A1 (en) 2010-12-31 2013-07-18 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
ES2707579T3 (es) 2011-06-01 2019-04-04 Celularity Inc Tratamiento del dolor usando citoblastos placentarios
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
DK2775928T3 (da) 2011-11-08 2019-05-27 Auxocell Laboratories Inc Systemer og fremgangsmåder til forarbejdning af celler
AU2012358810B2 (en) 2011-12-23 2018-03-15 DePuy Synthes Products, Inc. Detection of human umbilical cord tissue-derived cells
WO2013102219A1 (en) 2011-12-30 2013-07-04 Amit Patel Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses
US8940294B2 (en) 2012-03-02 2015-01-27 Tissuetech, Inc. Methods of isolating and culturing stem cells
WO2013149003A1 (en) 2012-03-28 2013-10-03 Purdue Research Foundation Methods and systems useful for foodborne pathogen detection
US9670457B2 (en) * 2012-05-08 2017-06-06 Stem Cell Reserve Lp Stem cells and matrix from cord tissue
EP2756754B1 (de) 2013-01-17 2017-01-04 Vita 34 Ag Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes
US9763983B2 (en) 2013-02-05 2017-09-19 Anthrogenesis Corporation Natural killer cells from placenta
WO2014140921A2 (en) 2013-03-15 2014-09-18 Larsson Marcus Kare Torleif Cells, methods and apparatuses for umbilical cord blood collection and isolation of cells
US10400211B1 (en) 2014-04-28 2019-09-03 Donnie Rudd Cell composition for tissue regeneration
USD748462S1 (en) 2014-08-11 2016-02-02 Auxocell Laboratories, Inc. Centrifuge clip
US9993748B2 (en) 2014-08-11 2018-06-12 Auxocell Laboratories, Inc. Centrifuge clip and method
US10542743B2 (en) 2015-01-05 2020-01-28 Hygieia Therapeutics Sdn Bhd Isolation, expansion and characterization of wharton's jelly mesenchymal stem cells
US10624931B2 (en) 2015-09-23 2020-04-21 Osiris Therapeutics, Inc. Umbilical tissue compositions and methods of use
US11542473B2 (en) 2016-10-21 2023-01-03 Amniotics Ab Methods and compositions for generating hematopoietic cells
WO2019080942A1 (en) * 2017-10-27 2019-05-02 Alis Pharma Ltd. EXTRACT OF FETAL TISSUES, METHODS OF PRODUCTION OF THE EXTRACT AND USE THEREOF
BR112020012436A2 (pt) 2017-12-22 2020-11-24 Chiesi Farmaceutici S.P.A. células estromais mesenquimais e métodos para obter células estromais mesenquimais do cordão umbilical
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof
US12460178B2 (en) 2018-04-12 2025-11-04 Cellresearch Corporation Pte. Ltd. Method of inducing or improving wound healing properties of mesenchymal stem cells
TWI882956B (zh) 2018-04-12 2025-05-11 新加坡商細胞研究私人有限公司 一種誘導或改善間質幹細胞傷口癒合特性的方法
EP3818145A1 (de) 2018-07-02 2021-05-12 Vetbiobank Neonatale stromazellen mit niedriger mhc-i-expression und verwendungen davon
WO2020256628A1 (en) 2019-06-20 2020-12-24 Amniotics Ab An apparatus for filtering amniotic fluid
WO2021003254A1 (en) * 2019-07-01 2021-01-07 Auxocell Laboratories, Inc. Cryopreservation medium comprising a tissue extract
KR20220104682A (ko) 2019-10-18 2022-07-26 암니오틱스 아베 양수로부터 양수 간엽 줄기 세포 및 이로부터 유도된 세포를 얻기 위한 프로세스 및 장치
WO2021092199A1 (en) 2019-11-08 2021-05-14 Kansas State University Research Foundation Isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells
EP3909593A1 (de) 2020-05-15 2021-11-17 Rigshospitalet Stammzellen zur behandlung von hautläsionen
US12435308B2 (en) 2020-11-06 2025-10-07 Amniotics Ab Immunomodulation by amniotic fluid mesenchymal stem cells
US20240400622A1 (en) 2021-09-23 2024-12-05 President And Fellows Of Harvard College Genetically encoded voltage indicators and uses thereof
WO2023223303A1 (en) 2022-05-20 2023-11-23 Alt Atlas Ltd. Novel cell lines and systems and methods for a machine learning manufacturing software platform that optimize unique functional ingredients and solutions for the biotech and foodtech industries

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2578743B3 (fr) * 1985-03-13 1987-06-12 Bontemps Raymond Procede de fabrication d'une preparation medicamenteuse a base de substance mesenchymateuse du type microsepteurs
SU1708328A1 (ru) * 1989-07-11 1992-01-30 Кемеровский государственный медицинский институт Способ изготовлени сосудистого протеза
US5919702A (en) * 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
US20050158289A1 (en) * 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
US7670628B2 (en) * 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
AUPQ147799A0 (en) * 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
EP2348104A1 (de) * 1999-08-05 2011-07-27 Mcl Llc Multipotente adulte Stammzellen und Isolierungsverfahren
US20020045260A1 (en) * 2000-10-17 2002-04-18 Shih-Chieh Hung Method of isolating mesenchymal stem cells
CA2444959C (en) * 2001-04-24 2014-07-08 Dolores Baksh Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
US7736892B2 (en) * 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
US20030161818A1 (en) * 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
CA2515469C (en) 2003-02-11 2013-12-17 John E. Davies Progenitor cells from wharton's jelly of human umbilical cord
CA2530732C (en) 2003-06-27 2015-03-31 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
EP1639099B1 (de) * 2003-06-27 2011-05-18 Université Laval Verfahren zur isolierung von zellen aus der nabelschnur
JP2007525979A (ja) 2004-03-05 2007-09-13 イー． デーヴィス，ジョン 間葉系前駆細胞無血清懸濁培養システム
CA2634820C (en) 2005-12-22 2021-05-25 Jane Ennis Viable cells from frozen umbilical cord tissue
US20090280093A1 (en) 2006-03-01 2009-11-12 The Regenerative Medicine Institute Compositions and populations of cells obtained from the umbilical cord and methods of producing the same
JP5431146B2 (ja) 2006-05-05 2014-03-05 デイビーズ，ジヨン・イー 免疫学的寛容および調節性前駆細胞

Also Published As

Publication number Publication date
CA2515469A1 (en) 2004-08-26
HK1084417A1 (en) 2006-07-28
KR101077760B1 (ko) 2011-10-27
JP4790592B2 (ja) 2011-10-12
US9611456B2 (en) 2017-04-04
US8481311B2 (en) 2013-07-09
EP2277992A3 (de) 2011-03-02
JP2006517102A (ja) 2006-07-20
DE602004028803D1 (de) 2010-10-07
US20050148074A1 (en) 2005-07-07
KR20050115862A (ko) 2005-12-08
CA2515469C (en) 2013-12-17
US20090269318A1 (en) 2009-10-29
US7547546B2 (en) 2009-06-16
WO2004072273A1 (en) 2004-08-26
AU2004210891B2 (en) 2008-09-25
BRPI0407221A (pt) 2006-01-31
IL202331A (en) 2011-08-31
IL170221A (en) 2010-11-30
US20130259840A1 (en) 2013-10-03
ES2351386T3 (es) 2011-02-03
EP2277992A2 (de) 2011-01-26
AU2004210891A1 (en) 2004-08-26
AU2008261123A1 (en) 2009-01-15
EP1594957A1 (de) 2005-11-16
PT1594957E (pt) 2010-11-30
US20170157180A1 (en) 2017-06-08
EP1594957B1 (de) 2010-08-25
US20160032241A1 (en) 2016-02-04
US9567564B2 (en) 2017-02-14

Similar Documents

Publication Publication Date Title
ATE478941T1 (de) Vorläuferzellen aus der wharton sulze von humanen nabelschnüren
ATE333849T1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
ATE193729T1 (de) Geminivirus-basiertes-genexpressionsystem
CY1118167T1 (el) Πρωτογενη και εγγυς ηπατικα βλαστοκυτταρα
BRPI0410185A (pt) composição para manter a viabilidade de um orgão e célula
ATE485371T1 (de) Varianten des menschlichen koagulationsfaktors vii
EP1649021A4 (de) Pflanzliche zellzyklusgene und verwendungsverfahren
BR0211079A (pt) Processos para a modificação genética de células hematopoiéticas progenitoras e empregos das células modificadas
DE60314565D1 (de) Kosmetische Hautpflegezusammensetzungen
FR09C0067I2 (fr) Agents contenant de l'acide carboxylique et leur utilisation dans la culture de plantes
BRPI0412871A (pt) combinações de substáncias ativas fungicidas
ES2116496T3 (es) Proceso para la preparacion de 1,4-disubstituido-5(4h)-tetrazolinonas.
ATE501635T1 (de) Chemische hemmstoffe des mismatch-repair
SE0203526L (sv) New use of dextran sulfate
ATE319681T1 (de) Herstellung von 4,4'-diketo-beta-karotenderivaten
EP1472375A4 (de) In kanzerösen mammazellen differentiell exprimierte genprodukte und ihre verwendungsverfahren
ATE544847T1 (de) Verwendung von dendritischen zellen, die interleukin 12 (il-12) exprimieren
ATE499383T1 (de) Eine methode zur herstellung von menschlichem natürlichem interferon-alpha
DK1366367T3 (da) Organtransplantatafstödning og tilknyttede tilstande
DE502004011187D1 (de) M-diaminobenzole und deren säureaddukte sowie deren verwendung in färbemitteln
RU99111148A (ru) Глазные капли
Eng et al. Effects of sunlight on encapsulated sprayable codling moth pheromone
DE60330565D1 (de) Anti-fragilis Antikörper und dessen Verwendungen
AU2012227326C1 (en) Progenitor cells from wharton's jelly of human umbilical cord

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties